Organization
Cedars-Sinai Comprehensive Cancer Center
7 abstracts
1 poster
Abstract
The ketogenic diet plus standard of care for adults with recently diagnosed glioblastoma: Results from a phase 1 trial.Org: Cedars-Sinai Comprehensive Cancer Center, Cedars-Sinai Medical Center, Cedars-Sinai Cancer, Massachusetts General Hospital, University of California Irvine,
Abstract
Radiogenomics of muscle invasive bladder cancer.Org: Cedars-Sinai Medical Center, Cedars-Sinai Comprehensive Cancer Center,
Abstract
Integrated survival analysis.Org: Cedars-Sinai Comprehensive Cancer Center, The Angeles Clinic and Research Institute, Marymount University Hospice,
Abstract
CDH12 and the development of the neuronal subtype in MIBC.Org: Cedars-Sinai Medical Center, Cedars-Sinai Comprehensive Cancer Center, Cedars-Sinai Medical Center Medical Genetics Prenatal Diagnosis Center, Samuel Oschin Comprehensive Cancer Institute,
Abstract
The influence of grade on mortality risk in salivary gland malignancy.Org: Cedars-Sinai Medical Center, Cedars-Sinai Medical Center Medical Genetics Prenatal Diagnosis Center, Cedars Sinai Medical Center, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
BELIMUMAB (BMAB), A FULLY HUMAN MONOCLONAL ANTIBODY TO B-LYMPHOCYTE STIMULATOR (BLYS), SHOWS BIOACTIVITY AND REDUCES SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITYOrg: LBSL02 Study Grp, Cedars-Sinai Comprehensive Cancer Center, UCLA Department of Medicine, Los Angeles Medical Center, UA AHSC,
Abstract
BELIMUMAB (FULLY HUMAN MONOCLONAL ANTIBODY TO BLYS) IMPROVED OR STABILIZED SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY AND REDUCED FLARE RATE DURING 3 YEARS OF THERAPYOrg: NSLIJHS, Lake Success, NY, Lake Success, NY, JHU, Baltimore, Cedars-Sinai Comprehensive Cancer Center,